Track the 欧林生物 share price and the full directors' dealings record of the company, a listed issuer based in China. Shares are quoted on CN CN, under the authority of SSE / SZSE (CSRC). Operating in the Health Care sector, 欧林生物 has logged 10 insider filings. Market capitalisation: €14.4bn. The latest transaction was disclosed on 12 May 2026 (Sale). Among the most active insiders: 陈克平. Every trade is free.
10
Insider Decl.
0
Thresholds
·
1 ops.
Buy Volume
·
9 ops.
Sell Volume
12Σ signal
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Fundamental score
Ranked 16,623 of 26,092 companies
43.2
score / 100
Value
35
Quality
51
FCF yld0.0%
Earn yld0.1%
EV/EBITDA·
ROE6.0%
Gross mgn93%
Net mgn3.2%
Debt/EBITDA5.1x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.